الفهرس | Only 14 pages are availabe for public view |
Abstract Our study conducted on 85 patients with SCD aged 2 - 18 years, 8.4% of patients showed high risk study and 12.0% were conditional. One high risk patient had the qualifying velocity in ACA only. Regression analysis showed transfusion and HU dose protective against stroke. Mean VCAM level was 1438.12 ± 848.2 ng / ml and significantly higher than of normal population and higher in patient with normal TCD (P. 038). However, correlation of VCAM level with TAMMvel using showed + ve correlation with (P. 041). Levels were higher in HbSÝ subgroup, higher bilirubin level (and frequency of blood transfusion). In SS subgroup, VCAM level was significantly correlated with severity frequency (P {u2264}. 001) and duration (P {u2264}. 001) of VOCs. Level was lower with HU treatment P. 041 |